Loading…
von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis
Nonsteroidal anti-inflammatory drugs (NSAIDs, inhibitors of cyclooxygenase enzymes that synthesize prostaglandins) inhibit angiogenesis essential for tissue repair and colon cancer growth. The mechanisms of NSAIDs inhibition of angiogenesis remain unexplained. Since hypoxia is a major stimulus for a...
Saved in:
Published in: | The FASEB journal 2002-02, Vol.16 (2), p.264-266 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 266 |
container_issue | 2 |
container_start_page | 264 |
container_title | The FASEB journal |
container_volume | 16 |
creator | Jones, Michael K Szabo, Imre L Kawanaka, Hirofumi Husain, Syeda S Tarnawski, Andrzej S |
description | Nonsteroidal anti-inflammatory drugs (NSAIDs, inhibitors of cyclooxygenase enzymes that synthesize prostaglandins) inhibit angiogenesis essential for tissue repair and colon cancer growth. The mechanisms of NSAIDs inhibition of angiogenesis remain unexplained. Since hypoxia is a major stimulus for angiogenesis, the aim of this study was to determine the molecular mechanism(s) of NSAIDs inhibition of hypoxia-induced angiogenesis in gastric microvascular endothelial cells (RGMEC). We studied whether NSAIDs affect expression levels of the hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha ) and/or the von Hippel Lindau tumor suppressor (VHL). The rationale for this study is that HIF-1 alpha and VHL control hypoxia-induced expression of VEGF (the most potent angiogenic factor) and its specific receptor, Flt-1, major mediators of hypoxia-induced angiogenesis. |
doi_str_mv | 10.1096/fj.01-0589fje |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17092251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17092251</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_170922513</originalsourceid><addsrcrecordid>eNqNzDtPwzAUBWAPIFEeI_ud2FyuUzUkbAioUgmxwF6Z5ia5kWub3JjHv8cDP6DTOTo6-pS6Nrg0WJe33bhEo3Fd1d1IJ2qBVV3oslxVZ-pcZEREg6ZcqPQVPDQcIzl4Yd_aBHM6hAkkxTiRSK7Wt9BsN9qAdXGwcA-evmG2U0-zQOjg9e1h-yTAfuAPnjmLeRx-Y_hhqzOa9tRmpefQkydhuVSnnXVCV_95oW42z--PjY5T-Ewk8-7AsifnrKeQZGfusC6KtVkdffwDWqhTgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17092251</pqid></control><display><type>article</type><title>von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Jones, Michael K ; Szabo, Imre L ; Kawanaka, Hirofumi ; Husain, Syeda S ; Tarnawski, Andrzej S</creator><creatorcontrib>Jones, Michael K ; Szabo, Imre L ; Kawanaka, Hirofumi ; Husain, Syeda S ; Tarnawski, Andrzej S</creatorcontrib><description>Nonsteroidal anti-inflammatory drugs (NSAIDs, inhibitors of cyclooxygenase enzymes that synthesize prostaglandins) inhibit angiogenesis essential for tissue repair and colon cancer growth. The mechanisms of NSAIDs inhibition of angiogenesis remain unexplained. Since hypoxia is a major stimulus for angiogenesis, the aim of this study was to determine the molecular mechanism(s) of NSAIDs inhibition of hypoxia-induced angiogenesis in gastric microvascular endothelial cells (RGMEC). We studied whether NSAIDs affect expression levels of the hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha ) and/or the von Hippel Lindau tumor suppressor (VHL). The rationale for this study is that HIF-1 alpha and VHL control hypoxia-induced expression of VEGF (the most potent angiogenic factor) and its specific receptor, Flt-1, major mediators of hypoxia-induced angiogenesis.</description><identifier>ISSN: 0892-6638</identifier><identifier>DOI: 10.1096/fj.01-0589fje</identifier><language>eng</language><ispartof>The FASEB journal, 2002-02, Vol.16 (2), p.264-266</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Jones, Michael K</creatorcontrib><creatorcontrib>Szabo, Imre L</creatorcontrib><creatorcontrib>Kawanaka, Hirofumi</creatorcontrib><creatorcontrib>Husain, Syeda S</creatorcontrib><creatorcontrib>Tarnawski, Andrzej S</creatorcontrib><title>von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis</title><title>The FASEB journal</title><description>Nonsteroidal anti-inflammatory drugs (NSAIDs, inhibitors of cyclooxygenase enzymes that synthesize prostaglandins) inhibit angiogenesis essential for tissue repair and colon cancer growth. The mechanisms of NSAIDs inhibition of angiogenesis remain unexplained. Since hypoxia is a major stimulus for angiogenesis, the aim of this study was to determine the molecular mechanism(s) of NSAIDs inhibition of hypoxia-induced angiogenesis in gastric microvascular endothelial cells (RGMEC). We studied whether NSAIDs affect expression levels of the hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha ) and/or the von Hippel Lindau tumor suppressor (VHL). The rationale for this study is that HIF-1 alpha and VHL control hypoxia-induced expression of VEGF (the most potent angiogenic factor) and its specific receptor, Flt-1, major mediators of hypoxia-induced angiogenesis.</description><issn>0892-6638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNzDtPwzAUBWAPIFEeI_ud2FyuUzUkbAioUgmxwF6Z5ia5kWub3JjHv8cDP6DTOTo6-pS6Nrg0WJe33bhEo3Fd1d1IJ2qBVV3oslxVZ-pcZEREg6ZcqPQVPDQcIzl4Yd_aBHM6hAkkxTiRSK7Wt9BsN9qAdXGwcA-evmG2U0-zQOjg9e1h-yTAfuAPnjmLeRx-Y_hhqzOa9tRmpefQkydhuVSnnXVCV_95oW42z--PjY5T-Ewk8-7AsifnrKeQZGfusC6KtVkdffwDWqhTgQ</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Jones, Michael K</creator><creator>Szabo, Imre L</creator><creator>Kawanaka, Hirofumi</creator><creator>Husain, Syeda S</creator><creator>Tarnawski, Andrzej S</creator><scope>7TO</scope><scope>H94</scope></search><sort><creationdate>20020201</creationdate><title>von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis</title><author>Jones, Michael K ; Szabo, Imre L ; Kawanaka, Hirofumi ; Husain, Syeda S ; Tarnawski, Andrzej S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_170922513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Michael K</creatorcontrib><creatorcontrib>Szabo, Imre L</creatorcontrib><creatorcontrib>Kawanaka, Hirofumi</creatorcontrib><creatorcontrib>Husain, Syeda S</creatorcontrib><creatorcontrib>Tarnawski, Andrzej S</creatorcontrib><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Michael K</au><au>Szabo, Imre L</au><au>Kawanaka, Hirofumi</au><au>Husain, Syeda S</au><au>Tarnawski, Andrzej S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis</atitle><jtitle>The FASEB journal</jtitle><date>2002-02-01</date><risdate>2002</risdate><volume>16</volume><issue>2</issue><spage>264</spage><epage>266</epage><pages>264-266</pages><issn>0892-6638</issn><abstract>Nonsteroidal anti-inflammatory drugs (NSAIDs, inhibitors of cyclooxygenase enzymes that synthesize prostaglandins) inhibit angiogenesis essential for tissue repair and colon cancer growth. The mechanisms of NSAIDs inhibition of angiogenesis remain unexplained. Since hypoxia is a major stimulus for angiogenesis, the aim of this study was to determine the molecular mechanism(s) of NSAIDs inhibition of hypoxia-induced angiogenesis in gastric microvascular endothelial cells (RGMEC). We studied whether NSAIDs affect expression levels of the hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha ) and/or the von Hippel Lindau tumor suppressor (VHL). The rationale for this study is that HIF-1 alpha and VHL control hypoxia-induced expression of VEGF (the most potent angiogenic factor) and its specific receptor, Flt-1, major mediators of hypoxia-induced angiogenesis.</abstract><doi>10.1096/fj.01-0589fje</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-6638 |
ispartof | The FASEB journal, 2002-02, Vol.16 (2), p.264-266 |
issn | 0892-6638 |
language | eng |
recordid | cdi_proquest_miscellaneous_17092251 |
source | Wiley-Blackwell Read & Publish Collection |
title | von Hippel Lindau tumor suppressor and HIF-1 alpha : new targets of NSAIDs inhibition of hypoxia-induced angiogenesis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=von%20Hippel%20Lindau%20tumor%20suppressor%20and%20HIF-1%20alpha%20:%20new%20targets%20of%20NSAIDs%20inhibition%20of%20hypoxia-induced%20angiogenesis&rft.jtitle=The%20FASEB%20journal&rft.au=Jones,%20Michael%20K&rft.date=2002-02-01&rft.volume=16&rft.issue=2&rft.spage=264&rft.epage=266&rft.pages=264-266&rft.issn=0892-6638&rft_id=info:doi/10.1096/fj.01-0589fje&rft_dat=%3Cproquest%3E17092251%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_170922513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17092251&rft_id=info:pmid/&rfr_iscdi=true |